Home
Scholarly Works
PGI1 Comparative efficacy and safety of golimumab,...
Conference

PGI1 Comparative efficacy and safety of golimumab, infliximab and adalimumab for the treatment of moderate to severe ulcerative colitis: A bayesian indirect treatment comparison meta-analysis

Authors

Thorlund K; Druyts E; Eapen S; Mills E

Volume

17

Publisher

Elsevier

Publication Date

May 1, 2014

DOI

10.1016/j.jval.2014.03.213

Conference proceedings

Value in Health

Issue

3

ISSN

1098-3015

Contact the Experts team